Quipt Home Medical Corp Sees Analyst Raise Price Target to $3.65, a 58.70% Increase

Quipt Home Medical's (QIPT) price target has been raised by Canaccord Genuity analyst Richard Close from $2.30 to $3.65, a 58.70% increase. The firm maintains its "Hold" rating, reflecting continued confidence in the company's strategic position and operational prospects. Quipt is a provider of durable medical equipment and home medical equipment in the US, specializing in respiratory diseases management. The average one-year price target is $3.10, with a high estimate of $4.50 and a low estimate of $1.70.